1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mGluR2-recept0r modulators

Details for Australian Patent Application No. 2007224431 (hide)

International Classifications

Event Publications

28 August 2008 PCT application entered the National Phase

PCT publication WO2007/104783 Priority application(s): WO2007/104783

27 November 2008 Assignment before Grant

Janssen Pharmaceutica N.V.; Addex Pharma S.A. The application has been assigned to Addex Pharma S.A.; OrthoMcNeil-Janssen Pharmaceuticals, Inc.

25 November 2010 Application Accepted

Published as AU-B-2007224431

13 January 2011 Corrigenda

Applications Accepted - Name Index Under the name Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Addex Pharma S.A., Application No. 2007224431, under INID (54) correct the title to read 1,4 - di substituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.